Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

The treatment is safe and shows promise for metastatic breast cancer.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Upadacitinib improved multiple immune-related conditions in one patient.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.